- Trials with a EudraCT protocol (90)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
90 result(s) found for: Activator.
Displaying page 1 of 5.
EudraCT Number: 2008-003371-53 | Sponsor Protocol Number: STROKE-FNUSA-01 | Start Date*: 2008-08-08 | |||||||||||
Sponsor Name:Fakultní nemocnice u svaté Anny | |||||||||||||
Full Title: Acute Stroke Study of Optimized tPA Dosing in Correlation with Artery Status | |||||||||||||
Medical condition: Patients with acute ischemic stroke with proven occlusion of major brain arteries demonstrated by transcranial ultrasound. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-000919-26 | Sponsor Protocol Number: IVH05 | Start Date*: 2005-07-29 |
Sponsor Name:Newcastle upon Tyne Hospitals NHS Trust [...] | ||
Full Title: Phase II, randomized, pharmokinetic, dose finding, and dose frequency determination using rt-PA in intraventricular hemorrhage | ||
Medical condition: Intracerebral haemorrhage with intraventricular extension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Completed) FI (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-003289-42 | Sponsor Protocol Number: 41399 | Start Date*: 2012-12-21 |
Sponsor Name:Academic Medical Center Amsterdam | ||
Full Title: Randomized Controlled Trial Investigating the Efficacy and Safety of Nebulized Heparin versus Placebo in Burn Patients with Inhalation Trauma | ||
Medical condition: Burn-associated inhalation trauma requiring intubation and mechanical ventilation. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-001640-26 | Sponsor Protocol Number: 132151 | Start Date*: 2020-04-17 |
Sponsor Name:University College London | ||
Full Title: A pilot, open label, phase II clinical trial of nebulised recombinant tissue-Plasminogen Activator (rtPA)in patients with COVID-19 ARDS: The Plasminogen Activator COVID-19 ARDS (PACA) trial | ||
Medical condition: Acute respiratory distress syndrome (ARDS) caused by COVID-19 | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: View results |
EudraCT Number: 2014-000377-40 | Sponsor Protocol Number: MST-188-07 | Start Date*: 2014-11-13 | |||||||||||
Sponsor Name:Mast Therapeutics, Inc. | |||||||||||||
Full Title: Evaluation of MST-188 in Acute Lower Limb Ischemia: A Phase 2 Randomized Double-Blind, Placebo-Controlled, Multi-Center Clinical Trial Evaluating the Safety and Efficacy Of MST-188 in Subjects with... | |||||||||||||
Medical condition: Acute Lower Limb Ischemia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: HU (Prematurely Ended) CZ (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-001317-28 | Sponsor Protocol Number: ABBA-2 | Start Date*: 2015-07-30 |
Sponsor Name:UMC Utrecht | ||
Full Title: A B2-agonist as a CFTR activator in CF - Part 2 | ||
Medical condition: Cystic fibrosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2006-001398-44 | Sponsor Protocol Number: PR 2006-04 | Start Date*: 2006-06-13 |
Sponsor Name:Barts and The London NHS Trust | ||
Full Title: The use of Peroxisome Proliferator Activator Receptor Agonists in the management of Androgen Independent Prostate Cancer | ||
Medical condition: The use of Peroxisome Proliferator Activator Receptor Agonists in the management of Androgen Independent Prostate Cancer. Open-labeled, non-randomised clinical trial in patients with androgen indep... | ||
Disease: | ||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2014-000057-37 | Sponsor Protocol Number: ABBA-2014 | Start Date*: 2014-04-30 |
Sponsor Name:University Medical Centre Utrecht | ||
Full Title: A B2-agonist as a CFTR activator in CF | ||
Medical condition: Cystic Fibrosis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2005-001218-42 | Sponsor Protocol Number: 177/2004/U/Sper | Start Date*: 2005-01-17 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI | |||||||||||||
Full Title: Clinical role of PPAR gamma activator (pioglitazone) in reducing the gastric phlogosis in patiens with istological gastritis. | |||||||||||||
Medical condition: Treatment of patients with gastric phlogosis (infected by Helicobacter pylori) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002478-30 | Sponsor Protocol Number: FLUSH | Start Date*: 2013-06-05 |
Sponsor Name:Leiden University Medical Center | ||
Full Title: Arterial perfusion with t-PA in donation after cardiac death (DCD) to reduce the incidence of non-anastomotic biliary strictures after orthotopic liver transplantation | ||
Medical condition: Biliary strictures after orthotopic liver transplantation caused by microthrombi in the donorliver during procurement | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2010-018637-21 | Sponsor Protocol Number: 1 | Start Date*: 2013-11-20 | ||||||||||||||||
Sponsor Name:Universitätsklinikum Schleswig-Holstein UKSH | ||||||||||||||||||
Full Title: Intravitreal Injection of Lucentis (Ranibizumab) after Pars Plana Vitrectomy and Subretinal Application of Recombinant Tissue Plasminogen Activator (rtPA) in Patients with Acute Submacular Hemorrha... | ||||||||||||||||||
Medical condition: exsudative age-related macular degeneration with acut submacular hemorrhage | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-001070-27 | Sponsor Protocol Number: EP-PAE Metalyse | Start Date*: 2005-07-07 |
Sponsor Name:Division of Angiology Graz | ||
Full Title: Open, randomised, monosite pilot trial for comparison of thrombolytic efficacy of tenecteplase and alteplase in patients with acute pulmonary embolism | ||
Medical condition: Patients with acute pulmonary embolism and indication for thrombolytic therapy are included in the study | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2010-019760-36 | Sponsor Protocol Number: T05018-2004 | Start Date*: 2010-11-22 | |||||||||||
Sponsor Name:Grifols Therapeutics, Incorporated | |||||||||||||
Full Title: A Phase 2, Randomized, Open-label (with Blinded Plasminogen Activator and Placebo Control Groups) Study to Evaluate the Effects of Different Intra-thrombus Infusion Regimens of Plasmin (Human) Comp... | |||||||||||||
Medical condition: acute peripheral arterial occlusion | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) HU (Prematurely Ended) DE (Prematurely Ended) BE (Completed) ES (Prematurely Ended) CZ (Completed) BG (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003176-38 | Sponsor Protocol Number: 135.312 | Start Date*: 2006-05-22 |
Sponsor Name:Boehringer Ingelheim Pharma Ges mbH | ||
Full Title: A placebo controlled trial of alteplase (rt-PA) in acute ischemic hemispheric stroke where thrombolysis is initiated between 3 and 4 hours 30 minutes after stroke onset | ||
Medical condition: Ischemic stroke 3 and 4 hours 30 minutes before treatment | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) SK (Completed) CZ (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-016007-39 | Sponsor Protocol Number: I2Q-MC-GMAJ | Start Date*: 2010-02-15 | |||||||||||
Sponsor Name:Eli Lilly and Company | |||||||||||||
Full Title: A 12-Week, Phase 2, Randomized, Double-Blind, Active-Controlled Study of LY2599506 Given as Monotherapy or in Combination with Metformin in Patients with Type 2 Diabetes Mellitus | |||||||||||||
Medical condition: Type 2 diabetes | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Prematurely Ended) ES (Completed) AT (Prematurely Ended) DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-006006-22 | Sponsor Protocol Number: ICH01 | Start Date*: 2009-01-14 | |||||||||||
Sponsor Name:Newcastle upon Tyne Hospitals NHS Trust [...] | |||||||||||||
Full Title: Minimally Invasive Surgery plus rt-PA for ICH Evacuation | |||||||||||||
Medical condition: intracerebral hemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2013-002818-12 | Sponsor Protocol Number: ICH02 | Start Date*: 2014-06-13 | |||||||||||
Sponsor Name:The John Hopkins University | |||||||||||||
Full Title: A phase III, randomized, open-label, 500-subject clinical trial of minimally invasive surgery plus rt-PA in the treatment of intracerebral haemorrhage. | |||||||||||||
Medical condition: Spontaneous supratentorial intracerebral haemorrhage | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) ES (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-003859-12 | Sponsor Protocol Number: 12-027 | Start Date*: 2013-07-19 | ||||||||||||||||
Sponsor Name:RWTH Aachen University for the Medical Faculty, represented by Clinical Trial Center Aachen (CTC-A) | ||||||||||||||||||
Full Title: Linagliptin as a modulator of vascular inflammation in patients with type 2 diabetes mellitus | ||||||||||||||||||
Medical condition: patients with type 2 diabetes mellitus and vascular inflammation | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2004-000238-36 | Sponsor Protocol Number: IST-399 | Start Date*: 1999-10-05 | |||||||||||
Sponsor Name:The University of Edinburgh & Lothian Health Board | |||||||||||||
Full Title: Third International Stroke Trial (IST-3) of thrombolysis for acute ischaemic stroke | |||||||||||||
Medical condition: Acute ischaemic stroke refers to strokes caused by thrombosis or embolism and accounts for 85% of all strokes. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) PT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002760-41 | Sponsor Protocol Number: CL2-RTCCAR-001 | Start Date*: 2017-09-18 | |||||||||||
Sponsor Name:institute de Recherches Internacionales Servier (promotor internacional) | |||||||||||||
Full Title: Assessment of Active Thrombin-Activatable Fibrinolysis Inhibitor (TAFIa) plasma kinetics in Patients at acute stage of Ischemic Stroke: Prospective, Multicentre, Open, Non-randomised, Biomarker Study | |||||||||||||
Medical condition: Acute Ischemic Stroke | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.